medigraphic.com
ISSN 1561-3011 (Electronic)

2011, Number 4

<< Back Next >>

Rev Cubana Invest Bioméd 2011; 30 (4)

Bioethical features in the treatments of stem cells

Cepero NFL, Hernández HBA, Carrero TY

Language: Spanish
References: 15
Page: 528-536
PDF size: 125.09 Kb.


ABSTRACT

The Bioethics became a necessary field in the science development from the three past decades of XX century. Concerning to researches with stem cells, have raised many debates from appeared the first studies with embryonic stem cells until present time where researches with above mentioned cells are developing to avoid the moral implications of human embryos use. The legislations are adapting to the new technologies and the researchers have to be updated on the guidelines and laws of daily appearance. A review on Bioethics in researches with stem cells is performed. Above researches have had confrontations with other disciplines and the use of mesenchymal stem cells came to solve the dilemmas regarding the embryos use. At moment to obtain the informed consent the patient must to know about the adverse effects of treatment.


REFERENCES

  1. Bognar A, Menz W. How Politics Deals with Expert Dissent: The Case of Ethics Councils. Science, Technology Human Values. 2010;35(6):888-914. originally published online 2 August 2010. Disponible en: http://sth.sagepub.com/content/35/6/888

  2. Ashcroft R. Futures for Bioethics. Bioethics. 2010;24(5)pii.

  3. Sarría Castro M. Bioética, investigación y salud pública, desde una perspectiva social. Rev Cubana Salud Públ. 2007;33(1).

  4. Robertson JA. Embryo Stem Cell Research: Ten Years of Controversy. Law, Science and Innovation: The Embryonic Stem Cell Controversy. Journal of Law, Medicine & Ethics. Summer 2010;38(2):191-203.

  5. Gómez-Lobo A. Fundamentaciones de la Bioética. Acta Bioethica. 2009;15(1):43-45.

  6. Agar N. Embryonic Potential and Stem Cells. Bioethics. 2007; 21(4):198-207.

  7. Soren H. Who Should Control the Use of Human Embryonic Stem Cells Lines: A Defence of the Donors'Ability to Control. Bioethical Inquiry. (2006);3:55-68.

  8. Baertschi B. Mauron A. Moral Status Revisited: The Challenge of Reversed Potency. Bioethics. 2010;24(2):96-

  9. Chen Shih-Jen, Chang Chia-Ming, Tsai Shen-Kou, Chang Yuh-Lih, Chou Shih-Jie, Huang Shiang-Suo, et al. Functional Improvement of Focal Cerebral Ischemia Injury by Subdural Transplantation of Induced Pluripotent Stem Cells with Fibrin Glue. Stem Cells and Development. 2010;19(11).

  10. Doeppner T, Dirk H. Mesenchymal Stem Cells in the Treatment of Ischemic Stroke: Progress and Possibilities. Stem Cells and Cloning: Advances and Applications 2010;3:157-163

  11. Mosna Federico. Sensebé Luc and Krampera Mauro. Human Bone Marrow and Adipose Tissue. Mesenchymal Stem Cells: A User Guide. Stem Cells and Development 2010;19(10).

  12. de Vries Rob BM, Oerlemans A, Trommelmans L, Dierick K, Gordijn B. Ethical Aspects of Tissue Engineering: Review. Tissue Engineering. Part B: Reviews. 2008;14:367-75.

  13. Becerra J, Santos Ruiz L, Andrades JA, Mari-Beffa M. The Stem Cell Niche. Should be a Key Issue for Cell Therapy in Regenerative Medicine. Cell Rev and Rep. 2010;30 October

  14. Amaro Cano MC. Reflexiones éticas sobre la investigación científica en Biomedicina desde el prisma de la Universidad Médica. Rev Cubana Invest Biomed. 2006;25(1).

  15. Resolución No. 219/07. Gaceta Oficial No. 029/2007 EXTRAORDINARIA. p. 129- 134. Gaceta Oficial de la República de Cuba, 18 de junio de 2007, Ministerio de Justicia, Año CV. ISSN 1682-7511. http://www.gacetaoficial.cu




2020     |     www.medigraphic.com